Angine-Angine BioTech Co., Ltd

CN

Angine News

Angine Assisted Kvvit Pharma to Sign Inbrija China Rights from Merz Th…
2026-05-31 13:02:49
May 26, 2026 – Jiangxi Kvvit Pharmaceutical Co., Ltd. (hereinafter referred to as “Kvvit”), a subsidiary of QF ...
Leo Luo, Founding Partner of Angine was invited to attend the 2025 Interph…
2025-10-26 12:19:11
From October 15th to 18th2025, during BioPlus-InterPhex, the annual biopharmaceutical conference held in Seoul,...
Angine BD Case: Angine successfully assisted a BD deal executed between …
2025-06-01 21:22:36
As a professional global BD consultant partner, Anginehasadvised Jincheng Pharma, a leading integratedpharmaceu...
The First China-Korea BioInnovation & BD Forum (CKBF) was Successf…
2024-05-27 17:54:38
The First China-KoreaBioInnovation &Forum(CKBF) was Successfully Held in HangzhouFrom May 21 to May 22, 202...

Angine Events

Angine BD Model

Discovery

Identifying and tracking global life science projects and the companies with the breakthrough innovation in the specified therapeutic areas
Evaluation

Initiate the initial evaluations to the target project by Angine BD team to identify the biz case with the CDA in place
Transaction

Sign the service agreement to initiate the BD partnership building with the potential partners in the great China region particularly
Development

To assist the clients to develop the project based on the signed agreement after the deal by providing the additional value.

Contact Angine

Email：bd@anginebio.com

Address： F15, Building E, HiPark, No.198, Qidi Road, Xiaoshan District, Hangzhou, Zhejiang, P.R.China (311200)